Clinical Trial Update: Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating vorinostat in combination with palliative radiotherapy for non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Yale University | Conditions: Non-Small Cell Lung Cancer (NSCLC) | Phase 1 | Status: COMPLETED | Results posted: 2013-01-17